Search results for: COVID-19 Research
Filter search results
Abolishing Pharmaceutical Rebates in the US? Looking at the Trade-Offs
12 March 2019
…Pharmaceutical Rebates. OHE Research Paper, London: Office of Health Economics. Hampson, G., Towse, A., Dreitlein, B., Henshall, C. and Pearson, S., 2018. Real World Evidence for Coverage Decisions: Opportunities and…
Does Free Personal Care for the Elderly Reduce Informal Caregiving?
25 February 2013
…costs is a topic for future research. Download Schaffer, Sarah Karlsberg. (2013) The effect of free personal care for the elderly on informal caregiving. Research paper 13/01. London: Office of…
Valuing Orphan Medicines Using Multi-Criteria Decision Analysis
7 May 2013
OHE has just released a research paper that describes an experimental study intended to test whether and how a multi-criteria decision analysis (MCDA) approach can be applied to orphan medicinal…
Can Transparency Lower Prices and Improve Access to Pharmaceuticals? Not So Fast…
28 March 2019
…on drug prices, revenues, research and development costs, public sector investments and research and development subsidies, marketing costs and other related information…”. But is price transparency the answer to healthcare…
The WHO Technical Report on the Pricing of Cancer Medicines: Missing a Central Role for Value Assessment
8 April 2019
…key to efficient pricing and use of cancer medicines. The Research Paper outlines some for addressing these shortcomings. A new OHE Research Paper by Simon Brassel, Olga Rozanova, and Adrian…
Anchoring Latent Scale Values for the EQ-5D-Y at 0 = Dead
20 January 2020
…of quality-adjusted life year (QALY) estimation. A new OHE Research Paper, authored by former OHE researcher Koonal Shah and OHE Senior Fellow Nancy Devlin, in collaboration with Juan Manuel Ramos-Goñi and Simone Kreimeier, compares four stated preference methods for…
The value of cell and gene therapies to the UK economy
20 October 2025
Share this: Download publication Chris Sampson Sukanya Subramaniyan Matthew Napier Hania El Banhawi Panos Kefalas Laura Beswick Jacqueline Barry Matthew Durdy Grace Hampson Key takeaways Our research estimates that widening…
Can the US Afford to Ignore Cost-Effectiveness Evidence in Health Care?
23 July 2013, 11:00pm
At this OHE Lunchtime Seminar, Dr James Chambers of Tufts University presented material drawing on his upcoming OHE Research Paper, which looks at the role cost-effectiveness evidence plays in health…
Christopher Henshall
30 August 2023
Christopher Henshall Ph.D. has worked in universities, research funding bodies and the UK Civil Service, including positions at the UK Medical Research Council, the Department of Health and the NHS…